Evidence mapPaperPMID 39451348Full record

ReviewBioengineering (Basel, Switzerland)2024

Interplay of Glucose Metabolism and Hippo Pathway in Chondrocytes: Pathophysiology and Therapeutic Targets.

Jacob Jahn, Quinn T Ehlen, Lee Kaplan, Thomas M Best, Zhipeng Meng, Chun-Yuh Huang

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jacob JahnUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0003-0745-7049
Quinn T EhlenUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.
Lee KaplanUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.
Thomas M BestUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0003-2836-161X
Zhipeng MengUniversity of Miami Miller School of Medicine, Miami, FL 33136, USA.
Chun-Yuh HuangUHealth Sports Medicine Institute, University of Miami, Miami, FL 33136, USA.ORCID 0000-0002-8848-258X

Funding

Roles of mechanotransduction in organ regeneration and fibrosisR35GM142504 · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2025 to 2025
$384k
NIGMS NIH HHS R35 GM142504
6 · The paper itself

Abstract

In this review, we explore the intricate relationship between glucose metabolism and mechanotransduction pathways, with a specific focus on the role of the Hippo signaling pathway in chondrocyte pathophysiology. Glucose metabolism is a vital element in maintaining proper chondrocyte function, but it has also been implicated in the pathogenesis of osteoarthritis (OA) via the induction of pro-inflammatory signaling pathways and the establishment of an intracellular environment conducive to OA. Alternatively, mechanotransduction pathways such as the Hippo pathway possess the capacity to respond to mechanical stimuli and have an integral role in maintaining chondrocyte homeostasis. However, these mechanotransduction pathways can be dysregulated and potentially contribute to the progression of OA. We discussed how alterations in glucose levels may modulate the Hippo pathway components via a variety of mechanisms. Characterizing the interaction between glucose metabolism and the Hippo pathway highlights the necessity of balancing both metabolic and mechanical signaling to maintain chondrocyte health and optimal functionality. Furthermore, this review demonstrates the scarcity of the literature on the relationship between glucose metabolism and mechanotransduction and provides a summary of current research dedicated to this specific area of study. Ultimately, increased research into this topic may elucidate novel mechanisms and relationships integrating mechanotransduction and glucose metabolism. Through this review we hope to inspire future research into this topic to develop innovative treatments for addressing the clinical challenges of OA.

Indexed as

chondrocyteglucosemechanotransductionmetabolismOA therapeuticsosteoarthritis

Identifiers

PMID39451348
PMCPMC11505586

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.